SCHEDULE 13D/AFiled Jan 8, 7:00 PM ET
Monte Rosa Therapeutics, Inc. SCHEDULE 13D/A
Versant Venture Capital VI, L.P.Summary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.